1. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase‐2 study (NordCML006). (13th September 2014) Authors: Hjorth‐Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta; Ehrencrona, Hans; Gedde‐Dahl, Tobias; Gjertsen, Bjørn Tore; Höglund, Martin; Koskenvesa, Perttu; Lotfi, Kourosh; Majeed, Waleed; Markevärn, Berit; Ohm, Lotta; Olsson‐Strömberg, Ulla; Remes, Kari; Suominen, Merja; Simonsson, Be... Journal: European journal of haematology Issue: Volume 94:Number 3(2015:Mar.) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐line treatment selection and early monitoring patterns in chronic phase‐chronic myeloid leukemia in routine clinical practice: SIMPLICITY. Issue 11 (25th September 2017) Authors: Goldberg, Stuart L.; Cortes, Jorge E.; Gambacorti‐Passerini, Carlo; Hehlmann, Rüdiger; Khoury, H. Jean; Michallet, Mauricette; Paquette, Ron L.; Simonsson, Bengt; Zyczynski, Teresa; Foreman, Aimee; Abruzzese, Elisabetta; Andorsky, David; Beeker, Aart; Cony‐Makhoul, Pascale; Hansen, Richard; Lomai... Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Imatinib and pegylated IFN‐α2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response. (28th January 2014) Authors: Koskenvesa, Perttu; Kreutzman, Anna; Rohon, Peter; Pihlman, Markus; Vakkila, Emmi; Räsänen, Anu; Vapaatalo, Mirja; Remes, Kari; Lundán, Tuija; Hjorth‐Hansen, Henrik; Vakkila, Jukka; Simonsson, Bengt; Mustjoki, Satu; Porkka, Kimmo Journal: European journal of haematology Issue: Volume 92:Number 5(2014:May) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. (November 2016) Authors: Söderlund, Stina; Christiansson, Lisa; Persson, Inger; Hjorth-Hansen, Henrik; Richter, Johan; Simonsson, Bengt; Mustjoki, Satu; Olsson-Strömberg, Ulla; Loskog, Angelica Journal: Leukemia research Issue: Volume 50(2016:Nov.) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. Issue 1 (31st October 2018) Authors: Hehlmann, Rüdiger; Cortes, Jorge E.; Zyczynski, Teresa; Gambacorti‐Passerini, Carlo; Goldberg, Stuart L.; Mauro, Michael J.; Michallet, Mauricette; Simonsson, Bengt; Williams, Loretta A.; Gajavelli, Srikanth; DeGutis, Irene; Sen, Ginny P.; Paquette, Ron L. Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗